Dr.
Ann de Wees Allen®, the inventor and Patent-holder of ArgMatrix®,
was the first scientist to discover a safe and effective Isoform
Pathway for L-arginine via inclusion of a “Blind Amino Acid®
Rider.”
For
this research, spanning over 25 years, Dr. Allen received
the first glycemic patent ever awarded worldwide, (named Breakthrough
Product of the Year by Success magazine) and the first patent
on L-arginine attached to a Blind Amino Acid Rider.
This
research resulted in the only long-term proven safe and efficacious
form of L-arginine, which has been validated by independent
authorities, as safe and legal for use by professional and
competitive athletes in all fields.
|
